Ignite Creation Date:
2024-05-06 @ 10:16 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03218436
Status:
COMPLETED
Last Update Posted:
2024-07-05
First Post:
2017-07-13
Brief Title:
Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia
Sponsor:
University Womens Hospital Tübingen
Organization:
University Womens Hospital Tübingen
Study Overview
Official Title:
Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
Active not recruiting
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAPCIN
Brief Summary:
Cervical intraepithelial neoplasia will be treated with physical low temperature plasma in the plasma cohort compared to watchful waiting in the control cohort
Primary endpoint after 3-6 months Pathological remission
Secondary endpoint HPV remission
Primary endpoint after 3-6 months Pathological remission
Secondary endpoint HPV remission
Detailed Description:
The study was completed with Less recruitment as it was planned due to overwhelming study success The study was published in August 2023 A link has been added to the Reference section
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None